1,4,7-triazacyclononane-n,n',n''-triacetic acid has been researched along with folic acid in 3 studies
Studies (1,4,7-triazacyclononane-n,n',n''-triacetic acid) | Trials (1,4,7-triazacyclononane-n,n',n''-triacetic acid) | Recent Studies (post-2010) (1,4,7-triazacyclononane-n,n',n''-triacetic acid) | Studies (folic acid) | Trials (folic acid) | Recent Studies (post-2010) (folic acid) |
---|---|---|---|---|---|
195 | 3 | 161 | 30,001 | 1,945 | 10,195 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Al-Hokbany, N; Al-Otaibi, B; Aljammaz, I; Amer, S; Okarvi, S | 1 |
Chen, Q; González Trotter, D; Haley, H; Lin, SA; Low, PS; McQuade, P; Meng, X; Miller, P; Rubins, D; Zeng, Z | 1 |
Appelhans, D; Boye, S; Daeg, J; Janke, A; Lederer, A; Shi, X; Temme, A; Voit, B; Xu, X; Zhao, J; Zhao, L | 1 |
3 other study(ies) available for 1,4,7-triazacyclononane-n,n',n''-triacetic acid and folic acid
Article | Year |
---|---|
Development and pre-clinical evaluation of new 68Ga-NOTA-folate conjugates for PET imaging of folate receptor-positive tumors.
Topics: Animals; Apoptosis; Cell Proliferation; Folic Acid; Folic Acid Transporters; Gallium Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Mice; Mouth Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2014 |
Synthesis and Preclinical Evaluation of Folate-NOTA-Al(18)F for PET Imaging of Folate-Receptor-Positive Tumors.
Topics: A549 Cells; Animals; Female; Fluorine Radioisotopes; Folate Receptors, GPI-Anchored; Folic Acid; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; KB Cells; Mice; Mice, Nude; Neoplasms; Positron-Emission Tomography; Radiochemistry; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 2016 |
Bivalent Peptide- and Chelator-Containing Bioconjugates as Toolbox Components for Personalized Nanomedicine.
Topics: Animals; Antigens, Surface; Avidin; Biotin; Chelating Agents; Contrast Media; Dendrimers; Diagnostic Imaging; ErbB Receptors; Folic Acid; Glutamate Carboxypeptidase II; HEK293 Cells; Heterocyclic Compounds, 1-Ring; Humans; Male; Mice, Inbred BALB C; Molecular Targeted Therapy; Nanomedicine; Peptides; Polyethylene Glycols; Prostatic Neoplasms; Xenograft Model Antitumor Assays | 2020 |